Accurate, handheld molecular diagnostics.

Our healthcare solution brings rapid, accurate pathogen detection directly where it’s needed — into clinics, medical offices and pharmacies. Empowering real-time, more informed care decisions.

doctor image

Meet be.well™, our simple, easy-to-use solution that puts molecular diagnostics and test results in the palm of your hand.

Alveo’s be.well™ system and companion mobile app are designed for point-of-care use and deliver rapid, accurate results to determine the presence or absence of disease.

father kissing baby

According to the World Health Organization, seasonal influenza epidemics result in three to five million cases of severe illness every year1.

Expanding healthcare provider access to rapid molecular detection is critical to global health in today’s interconnected world.

1  World Health Organization. Global influenza strategy 2019-2030, 2019.

Detecting pathogens at point-of-care to enable immediate intervention.

With an initial focus on acute respiratory infections including COVID-19, Flu A/B and RSV, be.well can be adapted to detect a wide range of diseases, bacteria and other pathogens that threaten public health.

Respiratory Health


Since the onset of the COVID-19 pandemic in 2019, global impact of respiratory illness continues to grow. Timely diagnosis is critical to healthcare providers to ensure appropriate, timely and effective care. Our be.well system uses molecular LAMP technology to enable rapid testing and action for the treatment and prevention of illness.

Contact us

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.